225 related articles for article (PubMed ID: 31104218)
1. A comparison of European, Polish, Slovenian and British EQ-5D-3L value sets using a Hungarian sample of 18 chronic diseases.
Zrubka Z; Beretzky Z; Hermann Z; Brodszky V; Gulácsi L; Rencz F; Baji P; Golicki D; Prevolnik-Rupel V; Péntek M
Eur J Health Econ; 2019 Jun; 20(Suppl 1):119-132. PubMed ID: 31104218
[TBL] [Abstract][Full Text] [Related]
2. Towards a Central-Eastern European EQ-5D-3L population norm: comparing data from Hungarian, Polish and Slovenian population studies.
Zrubka Z; Golicki D; Prevolnik-Rupel V; Baji P; Rencz F; Brodszky V; Gulácsi L; Péntek M
Eur J Health Econ; 2019 Jun; 20(Suppl 1):141-154. PubMed ID: 31102159
[TBL] [Abstract][Full Text] [Related]
3. Parallel Valuation of the EQ-5D-3L and EQ-5D-5L by Time Trade-Off in Hungary.
Rencz F; Brodszky V; Gulácsi L; Golicki D; Ruzsa G; Pickard AS; Law EH; Péntek M
Value Health; 2020 Sep; 23(9):1235-1245. PubMed ID: 32940242
[TBL] [Abstract][Full Text] [Related]
4. In search of a 'pan-European value set'; application for EQ-5D-3L.
Sajjad A; Versteegh MM; Santi I; Busschbach J; Simon J; Roijen LH
BMC Med Res Methodol; 2023 Jan; 23(1):13. PubMed ID: 36635625
[TBL] [Abstract][Full Text] [Related]
5. Interim EQ-5D-5L Value Set for Poland: First Crosswalk Value Set in Central and Eastern Europe.
Golicki D; Niewada M; Hout BV; Janssen MF; Pickard AS
Value Health Reg Issues; 2014 Sep; 4():19-23. PubMed ID: 29702801
[TBL] [Abstract][Full Text] [Related]
6. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
[TBL] [Abstract][Full Text] [Related]
7. General population reference values for 3-level EQ-5D (EQ-5D-3L) questionnaire in Poland.
Golicki D; Niewada M
Pol Arch Med Wewn; 2015; 125(1-2):18-26. PubMed ID: 25578383
[TBL] [Abstract][Full Text] [Related]
8. EQ-5D in Central and Eastern Europe: 2000-2015.
Rencz F; Gulácsi L; Drummond M; Golicki D; Prevolnik Rupel V; Simon J; Stolk EA; Brodszky V; Baji P; Závada J; Petrova G; Rotar A; Péntek M
Qual Life Res; 2016 Nov; 25(11):2693-2710. PubMed ID: 27472992
[TBL] [Abstract][Full Text] [Related]
9. [Assessment of health-related quality of life in psoriasis patients in Hungary].
Poór AK; Sárdy M; Cserni T; Brodszky V; Holló P; Gulácsi L; Remenyik É; Szegedi A; Rencz F; Péntek M
Orv Hetil; 2018 May; 159(21):837-846. PubMed ID: 29779387
[TBL] [Abstract][Full Text] [Related]
10. Parallel Valuation: A Direct Comparison of EQ-5D-3L and EQ-5D-5L Societal Value Sets.
Law EH; Pickard AS; Xie F; Walton SM; Lee TA; Schwartz A
Med Decis Making; 2018 Nov; 38(8):968-982. PubMed ID: 30403577
[TBL] [Abstract][Full Text] [Related]
11. Valuation of EQ-5D-3l Health States in Slovenia: VAS Based and TTO Based Value Sets.
Prevolnik Rupel V; Srakar A; Rand K
Zdr Varst; 2020 Mar; 59(1):8-17. PubMed ID: 32952698
[TBL] [Abstract][Full Text] [Related]
12. EQ-5D-5L Slovenian population norms.
Prevolnik Rupel V; Ogorevc M
Health Qual Life Outcomes; 2020 Oct; 18(1):333. PubMed ID: 33028345
[TBL] [Abstract][Full Text] [Related]
13. Population-level norm values by EQ-5D-3L in Hungary - a comparison of survey results from 2022 with those from 2000.
Inotai A; Nagy D; Kaló Z; Vokó Z
Qual Life Res; 2024 Jun; ():. PubMed ID: 38839684
[TBL] [Abstract][Full Text] [Related]
14. Valuation of EQ-5D-5L Health States in Poland: the First EQ-VT-Based Study in Central and Eastern Europe.
Golicki D; Jakubczyk M; Graczyk K; Niewada M
Pharmacoeconomics; 2019 Sep; 37(9):1165-1176. PubMed ID: 31161586
[TBL] [Abstract][Full Text] [Related]
15. General population normative data for the EQ-5D-3L in the five largest European economies.
Janssen MF; Pickard AS; Shaw JW
Eur J Health Econ; 2021 Dec; 22(9):1467-1475. PubMed ID: 34117986
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life in residents aged 18 years and older with and without disease: findings from the First Provincial Health Services Survey of Hunan, China.
Deng X; Dong P; Zhang L; Tian D; Zhang L; Zhang W; Li L; Deng J; Ning P; Hu G
BMJ Open; 2017 Sep; 7(9):e015880. PubMed ID: 28871016
[TBL] [Abstract][Full Text] [Related]
17. Quality of life after hip, vertebral, and distal forearm fragility fractures measured using the EQ-5D-3L, EQ-VAS, and time-trade-off: results from the ICUROS.
Svedbom A; Borgström F; Hernlund E; Ström O; Alekna V; Bianchi ML; Clark P; Curiel MD; Dimai HP; Jürisson M; Uusküla A; Lember M; Kallikorm R; Lesnyak O; McCloskey E; Ershova O; Sanders KM; Silverman S; Tamulaitiene M; Thomas T; Tosteson ANA; Jönsson B; Kanis JA
Qual Life Res; 2018 Mar; 27(3):707-716. PubMed ID: 29235059
[TBL] [Abstract][Full Text] [Related]
18. Does the choice of EQ-5D tariff matter? A comparison of the Swedish EQ-5D-3L index score with UK, US, Germany and Denmark among type 2 diabetes patients.
Kiadaliri AA; Eliasson B; Gerdtham UG
Health Qual Life Outcomes; 2015 Sep; 13():145. PubMed ID: 26374709
[TBL] [Abstract][Full Text] [Related]
19. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients.
Poór AK; Rencz F; Brodszky V; Gulácsi L; Beretzky Z; Hidvégi B; Holló P; Kárpáti S; Péntek M
Qual Life Res; 2017 Dec; 26(12):3409-3419. PubMed ID: 28875430
[TBL] [Abstract][Full Text] [Related]
20. Concordance among Swedish, German, Danish, and UK EQ-5D-3L Value Sets: Analyses of Patient-Reported Outcomes in the Swedish Hip Arthroplasty Register.
Teni FS; Rolfson O; Berg J; Leidl R; Burström K
J Clin Med; 2021 Sep; 10(18):. PubMed ID: 34575317
[No Abstract] [Full Text] [Related]
[Next] [New Search]
